Managing behavioral health in persons withdementia is an enormous and growing problem. Most patients with Alzheimer's disease (AD) have challengingneuropsychiatric symptoms such as agitation. These symptoms are distressing andoften overwhelming for caregivers often resulting in institutionalization andincreased healthcare utilization. Several medications are used off-labelto treat these symptoms including antidepressants, antipsychotics,anticonvulsants, anxiolytics and cholinesterase inhibitors. But manyregulatory bodies, professional associations, and patient advocacy groups havepromoted initiatives to decrease the inappropriate use of medications andencourage the use of alternatives, particularly behavioral interventions. The combination of dextromethorphan hydrobromideand quinidine sulfate (Nuedexta) has been recently studied for the off-labeltreatment of agitation in Alzheimer’s disease. A patient-centered, systematic, andevidence-based approach should be considered when addressing the behavioral and psychological symptoms of dementia.
Top Ten Things Every Clinician Should Know About the 2017 Hypertension Guidelines
Where is the COMPASS Taking Us? Rivaroxaban, Aspirin, or Both for Stable CVD ?
Azithromycin to Prevent Asthma Exacerbations: What AMAZES Us and What Doesn’t
Painstaking Efforts to Improve Opioid Stewardship
Painting a New CANVAS for SGLT-2 Inhibitors?
Validating HERDOO2 - When is it Safe to Stop Therapy After an Unprovoked VTE?
Testing the Limits on Blood Glucose Monitoring: Can We Safely Cut Back?
Are Statins ALL THAT for Primary Prevention in Older Adults? A Second Look at ALLHAT-LLT
Wrapping up Knee Pain: Cabbage Leaf Wraps for Osteoarthritis of the Knee
All for One and FOURIER for All!
Vitamin D to Prevent Respiratory Tract Infections: Is the Evidence Dazzling or Disappointing?
It’s All Relative: EINSTEIN CHOICE - Rivaroxaban for Extended Secondary Prevention of VTE
Peeling Back the Layers on Coated Aspirin
Antithrombotic Therapy Following Stent Placement in Patients with A-Fib: Should DOACs Be Preferred?
Getting Some SHUTi: Using the Internet to Treat Patients with Insomnia
Think Before You Make a RAS Decision: Evaluating the Use of RAS Blockers in Patients with Diabetes
Helpful, Harmful, or Futile — Antidepressant Use in Patients with Heart Failure
Top Ten Pitfalls to Avoid When Evaluating the Primary Literature
Is there a Role for Fixed-Ratio Injectable Combinations in Type 2 Diabetes?
Bowel Cleansing Regimens – Pick Your Poison (Wisely)!
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive